An in vitro model for partial-thickness cutaneous wound healing is described in which the influence of variables present in vivo, such as blood-borne factors and inflammatory cells, is eliminated. Dermal sheets of porcine skin are maintained in culture at the air-liquid interface in serum-free medium, and re-epithelialization from the keratinocytes of the hair infundibula can be studied.
An in vitro model for partial-thickness cutaneous wound healing is described in which the influence of variables present in vivo, such as blood-borne factors and inflammatory cells, is eliminated. Dermal sheets of porcine skin are maintained in culture at the air-liquid interface in serum-free medium, and re-epithelialization from the keratinocytes of the hair infundibula can be studied.
Dermal sheets of different thicknesses harvested from various depths were first evaluated for viability and regenerative potential in serum-supplemented medium. Mid-dermal explants, 20/1000 inch thick, showed the greatest epithelial outgrowth from the appendigeal keratinocytes and the longest viability in vitro. Explants of this type were used in all subsequent experiments.
The effects of growth factors on re-epithelialization of the T he m;yority of investigations on cutaneous wound healing have concentrated on dermal repair or wound bed remodeling (1-4) with little emphasis on epidermal regeneration. In partial-thickness wounds, reepithelialization occurs via epibolic outgrowth ofkeratinocytes from epidermal appendages in the wound bed and from viable epidermis at the wound edge. Epidermal wound healing is a complex process involving both migration and proliferation ofkeratinocytes under the influence of chemical attractions. These include growth factors, cytokines, and extracellular matrix proteins which are present in the serum or may be secreted locally by inflammatory cells, cells of the immune system, fibroblasts, endothelial cells, or keratinocytes themselves.
Several studies have shown that the topical application of mitegens can accelerate wound healing in vivo (5-1 OJ. However, the short time course (3 -5 d) of spontaneous re-epithelialization ([11), unpublished observations) and the synergistic effects of endogenous mitogens make it difficult to define the direct effects of an applied factor. Recently, cultured human epithelial allografts have been used as wound dressings to promote re-epithelialization of nonhealing partial-thickness wounds such as chronic ulcers (12 -15) . The relative contributions from keratinocytes of the wound edge and the wound bed are difficult to determine in clinical studies. Also, it is unclear whether the process of immunologic graft rejection has an additional stimulatory effect. We have developed an in vitro model of epidermal wound healing in which re-epithelialization of porcine mid-dermal sheets occurs via keratinocyte outgrowth from the infundibula of hair follicles. This model simulates epidermal regeneration from follicular outgrowth in a partial-thickness cutaneous wound in the absence of circulating factors, inflammation, or immunologic responses. The promotiona l effects of cultured human keratinocyte sheets and topical applications of growth factors such as cholera toxin (CT), epidermal growth factor (EGF) , insulin-like growth factor (IGF), and bombesin on epidermal regeneration are compared.
MATERIALS AND METHODS

Explant Preparation
The epidermis (20/1000 inch) was first removed from paravertebral areas of5-month-old female Yorkshire pigs (Parsons, lnc.,.Hadley, MA) with a Padgett's dermatome. Dermal sheets of various thicknesses (10-40/1000-inch) were then harvested with the dermatome from discrete areas of the exposed dermis. In addition, dermal sheets of 20/1 000-inch thickness were collected by serially cropping a single area. Different levels and thicknesses of explants are shown in The dermal sheets were co llected in serum-free Dulbecco-Vogt modified Eagle m edium (DM.EM) (Hazelton Biologics, Inc. , St. Lenexa, KS). Squares (0.5 cm 2 ) of dermis containjng at least 12 truncated hair follicles were placed o nto dressing sponges in multiwell Petri dishes (Fig 2a) and maintained at the air-liquid interface in 95% humidity at 37°C. Initially, explants were maintained in DM.EM with 10% FCS (Sigma Chem ical Co., St. Louis, MO) to determine the optimal level and thickness of dermis suitable for explants. T he med ium, suppleme nted with penicill in (1 ,000 U jml) , and streptomycin (1 mgjml), was changed every 3-4 d. Hydrocortisone (0 .4 ,ugfml, Calbioc hem, La Jolla, CA) was added to the medium in a concentration low enou gh not to inhibit ce ll proliferation but high enough to prevent glycoge n deposition and necrosis of rema inin g appendi geal keratinocytes and to inhibit collage nase activity (1 6] . The C0 2 concentration was maintained at 10% instead of the usual 5%, because a more acidic pH redu ces collage nase secretion of fibroblasts in vitro [ 17] .
All growth factor and keratinocyte experiments were performed in serum-free DMEM. Co,ntrol explants were kept in serum-free DM.EM and treated with topical applications of di luent for mitogens alone.
Histologic Analysis Hematoxylin and eosin-s tained sections of forma lin-fi xed, paraffin-embedded explants were examined for tissue viability. Portions of selected explants were fixed in 2.5% glu-THE JOURNAL OF I NVESTIGATIVE DERMATOLOGY taraldehyde, embedded in plastic, and eva luated ultras tructurally fo evidence of tissue degeneration (autolys is or collagen breakdovvn), Mitogen Preparation Growth factors were diluted in steril~ water with either 1 o/o bovine serum albumin (bombesin , EGF, IGF) or serum -free medium (CT), and applied topically to the surface 0 ' explants by micropipette (maximum volume 100 ,ul). Dose-_ response curves throu gh th e followin g concentratio ns were oh.. rained: bombesin (6 -600 nM, Sigma C hemical Co., St. Loui MO); cholera toxin (0.01 -1 nM, Schwarz/Mann Biotech, Ca01~ bridge, MA); human recombinant EGF (0.2-20 nM, ge nerous gift of Ch iron Corp., Emeryvil le, CA); and human recombinant IGI\ (1 -100 nM, Bachem, Torrance, CA). T h e lowest maximally effec, tive concentration for each growth factor was used in all subsequent experi ments. For the fo ll owing combinations of bombesin + CT, bombesin + IGF, and CT + IGF, the lowest maximally effectiv~ concentration of each mitogen was used. Each concentration o growth fac tor was tested in a total of 12 explants.
Cultured Keratinocyte Sheets Sheets were generated fro ll\ fres h and froze n newborn foreskin keratinocytes and grown on a lethally irradiated 3T3 fibroblast feeder layer (1 8, 19] . Cell sbee were detached w ith 0.25% Dispase solution and transferred to the exp lant surface on silastic sheeting (Dow Corning, Midland, MI), which was removed after placem ent of the cultured xenografts on the exp lant surface. Keratinocyte sheets from second, third , and fourt h passages were placed onto the explant surface at day 0 and lefi in place until harves ting. Control explants were covered witn VOL. 95, NO. 3 SEPTEMBER 1990 Kal tostat absorbent hemostatic wound dressing (BritCair Limited, Alders hot, UK (20]) .
Morphometric Analysis At least 10 hair follicles per explant were photographed en face under the microscope (Fig 2b) . Epithelial outgrowth was determined by computerized morphometric analysis from photomicrographs of the explant surface (total magnification X 50). Relative outgrowth was determined as the ratio of the perifollicular area covered by epithelium to the crosssectional area of the hair follicle using the RS/1 program by BBN (mean, standard variation, SEM).
RESULTS
Exflant Cultivation
The optimal thickness and depth of derma sheets to be used as explants were determined in DMEM supplemented with 10% FCS. Dermal sheets of different thicknesses (10/1 000, 20/1000, 30/1000, and 40/1000 inch) were first harvested from discrete areas (Fig 1) . The greatest degree of epithelial outgrowth and longest viability in vitro was observed with 20/1 000-inch-thick explants. Among 20/1000-inch explants from different dermal depths (superficial dermis to the subcutaneous adipose tissue), the great~st regenerative ~otential ~as ass?ciated wit_ h mid-dermal sheets (F1g 3a) that contamed the mfund1bula of ha1r follicles. The keratinocytes of the infundibula gave rise to the regenerating epidermis. After a 3-d incubation in serum-supplemented DMEM, centrifugal migration of keratinocytes was seen around all follicles (Fig 3b) . By day 6, bridging of adjacent perifollicular epithelial collars was observed. After 12 d, the regenerating epithelium was about 70% confluent. The regenerated epidermis appeared slightly thinner and less well organized than normal porcine skin (Fig 3c) . The basal cell layer was well organized, but the stratum corneum was either absent or poorly developed. In serumfree DMEM, epithelial outgrowth slowed markedly after 3-4 d. After 12 d narrow perifollicular epithelial collars had formed, but bridging between adjacent collars was not observed. The total absence of serum did not affect the viability or histologic appearance of explants. There were no signs of collagen breakdown or necrosis in the dermis by either light or electron microscopic examination. The nuclei appeared healthy and the cytoplasm of keratinocytes was non-vacuolated.
Treatment with Cultured Keratinocytes Application of cultured keratinocyte sheets to the explant surface in serum-free medium greatly increased epithelial outgrowth. Re-epithelialization of the explant surface by keratinocytes clearly originating from follicular infundibula was observed beneath the intact xenograft on histological examination at day 4 (Fig 4a) . At 6 d, the remains of the degenerating overlying xenograft were still identifiable, but the explant had regenerated a confluent well-differentiated epidermis (Fig 4b) . The newly formed epidermis was fully stratified and had a thin stratum corneum. Even deep dermal explants, which on initial screening in serum-supplemented medium displayed limited potential for re-epithelialization, regenerated a confluent epidermis which was thicker than normal porcine epidermis within 10 d following topical application of cultured keratinocyte sheets. Serial subculture of human keratinocytes prior to topical application to explants did not diminish their epithelial growth-promoting activity.
Treatment with Growth Factors
In dose-response determinations, the lowest concentration producing maximum outgrowth in asingle application was 1 nM for CT, 60 nM for bombesin, 10 nM for IGF, and 2 nM for EGF. Reapplication of mitogen further increased outgrowth in some cases. A second application ofbombesin, EGF, or IGF increased re-epithelialization significantly over that produced by a single dose (Fig 5) . However, reapplication of CT at a aose of 1 nM or greater had no additional effect. Among mitogen combinations, CT + IGF and CT + bombesin increased epithelial outgrowth only slightly over that observed with CT alone (Fig 6) . However, none of the mitogen combinations produced complete re-epithelialization of the explants (Fig 7) . On histologic examination, regenerated epidermis in explants treated with CT, alone or in combination with other mitogens, appeared hyperplastic and was 10 cell layers thick. Compared to explants grown in FCS-supplemented DMEM (Fig 3c) , the basal layer of the regenerated epidermis had an irregular contour and contained multiple mitotic figures (Fig 3d) . Bombesin-and IGFtreated explants showed a slightly less hypertrophic epithelium (6-8 cell layers thick) with a lower mitotic index. 
DISCUSSION
We h ave fo und that mid-dermal sheets measuring 20/1000 inch in thickness constitute the optimal explant type for use in investigating epidermal wo und healing of those large partial-thickness cutaneous wounds (e. g., donor sites for split-thickness skin grafts in_ b~rn patients), in which the wound edge is remote and re-ep1theltahzatwn occurs largely fro m epidermal aprendages in tl_1 e wound bed. As previously shown by Lenoir et al[21 ] , the keratmocytes of dermal explants will regenerate an epidermis via epibolic outgrowth from hai r follicles. In contrast to the situation in vivo, however, wound healing ca n be observed in an environment devoid of ci rcul ating growth factors and inflammatory products.
Previously described cutaneous organ culture systems have employed ex plants comprised predominantly (up to 80 %) of epidermis in w hich keratinocyte outgrowth from the explant periphery is observed {22-30) , simulating epithelial regeneration from the wound edge. The biologic responsiveness of interfollicular keratinocytes may be different from keratinocytes of hair follicles. In our explant model, the regenerative potential of skin appendages can be studied in isolation.
Interfollicul ar epithelial bridging was seen almost exclusively in serum-maintained explants, . Migration ofkeratinocytes is facilitated by serum proteins such a/ thrombospondin, fibronectin, epibolin and co-epibolin [31 ,32}. Perifollicular epithelial bridging was seen in some explanrs treated with EGF, but EGF is known to stimulate migration ofkeratinocytes [33) . Human recombinant EGF failed to promote follicular outgrowth significantly in porcine explants. AI- nocytes to human recombinant EGF (also see [38] ) suggests a species-specific difference in the EGF-receptor. Bombesin, known as a potent mitogen for 3T3 fibroblasts [39] . was found to induce epiderm al rege neration. In vivo, it is difficult to assess the direct growth-promoting effect of bombes in because the administration of this peptide stimulates the secretion of other biologically active peptides w hich might act as proximal effectors of bom besin and mask its direct effects. In this serum-free explant model, the so urce of proximal effec tors ofbombesin was limited to dermal, vascular o r epidermal appendigeal cells from the explant. Al though re-epithelialization m ay have bee n promoted directly by bombesin, products secreted by bombesin-stimulated fibrobl asts may be the principal promoters.
C h olera toxin, a potent cAMP promoter and highly effective mitogen for human keratinocytes in culture [ 40,4 1] , stimulates epidermal gro w th in vivo after intradermal injection in mice, rats and hamste rs [42] . In our model, CT proved to be a potent local promoter of epidermal re generatio n. It was not, however, as effective as cultured keratinocyte sheets. Our findin g that IGF alone did no t significantl y promote epithelial outgrowth but proved to be synergistic in combination with other growth factors is similar to that of other investigators [43] .
Re-epithelialization of explants treated with cultured human lreratinocyte sheets occurred at leas t three times faster than se ruminduced regeneration. An immunohistochemical labeling of theregenerated epidermis in explants after treatment w ith cultured human keratinocyte sheets was considered, but no anti-keratinocyte nor a nti-basement membrane antibody from commercial or private sou rces that was (human vs pig) species-specific was found. Because the grafts were of foreskin origin, a human Y chromosome analysis could be done, as has been done clinicall y to show that cultured allog rafts do not survive on treated ulcers [13] . H owever, it seemed clear from microscopic examination that the human grafts remain only as keratinaceous debris over the explant surface after 6 d.
These results support clinical observations that cultured human keratinocyte grafts promote wound healing. Healing of chronic ulcers refractory to conventional therapies is m arkedl y enhanced usi ng cultured allografts [13 ,15] . The cultured allografts do no t remain permanentl y on the wound bed [12] , and their mechanism of KERATINOCYTE SHEETS ENHANCE RE-EPITHEL!ALIZATION 345 action has been attributed to stimulation of endogenous keratinocytes via secretion of cytokines by inflammatory cell s or stimul ation of the immune system by the presence offoreign tissue [44] . Inflammatory and immune reactions are eliminated in the described explant model, indicating that enh ancement of re-epitheliali zation may be attributed solely to products secreted by the cultured kerat'inocytes. C ul tured human keratinocytes have bee n shown to produce basic fib rob last growth factor (45] . transforming growth factor-a (46, 47] , and many cytokines [48] [49] [50] [51] . They also secrete fib ro nectin , laminin, and thrombospondin, extracellular matrix proteins, w hi ch promote epithelial cell attachment and spreading [5 2 -58] . During the 3-week rejection phase, the secretion of mttoge ns and extracellular matrix proteins stimulate the patient's own keratinocyte to h eal the wound. Human dermal explants are presently being tested in this model to further elucidate species differences in responsiveness. 
